Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...
Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...
LAKE FOREST, Calif. & WOODLAND PARK, N.J.--(BUSINESS WIRE)--Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today ...
Inherently vulnerable to viral contamination, biologics rely on animal- or human-derived starting materials and complex manufacturing processes. Albeit rare, viral contamination incidents are ...
FORT DETRICK, Md. – Researchers at the U.S. Army Medical Research Institute of Infectious Diseases are testing a promising new biological threat detection method in high-fidelity training scenarios, ...
Results of a cross-sectional survey to explore determinants of health-promoting activities among Hispanic/Latino (H/L) patients (pts) with prostate cancer (PCa) on androgen deprivation therapy (ADT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results